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License 4.0 (CC BY-NC).DNA methylation as a mediator of the association
between prenatal adversity and risk factors for
metabolic disease in adulthood
Elmar W. Tobi,1,2 Roderick C. Slieker,1 René Luijk,1,3 Koen F. Dekkers,1 Aryeh D. Stein,4
Kate M. Xu,3,5 Biobank-based Integrative Omics Studies Consortium,* P. Eline Slagboom,1
Erik W. van Zwet,3 L. H. Lumey,1,6† Bastiaan T. Heijmans1†‡Although it is assumed that epigenetic mechanisms, such as changes in DNA methylation (DNAm), underlie the rela-
tionship between adverse intrauterine conditions and adult metabolic health, evidence from human studies remains
scarce. Therefore, we evaluated whether DNAm in whole blood mediated the association between prenatal famine
exposure and metabolic health in 422 individuals exposed to famine in utero and 463 (sibling) controls. We im-
plemented a two-step analysis, namely, a genome-wide exploration across 342,596 cytosine-phosphate-guanine di-
nucleotides (CpGs) for potential mediators of the association between prenatal famine exposure and adult body mass
index (BMI), serum triglycerides (TG), or glucose concentrations,whichwas followedby formalmediation analysis. DNAm
mediated the association of prenatal famine exposure with adult BMI and TG but not with glucose. DNAm at PIM3
(cg09349128), a gene involved in energy metabolism, mediated 13.4% [95% confidence interval (CI), 5 to 28%] of the
association between famine exposure and BMI. DNAm at six CpGs, including TXNIP (cg19693031), influencing b cell
function, and ABCG1 (cg07397296), affecting lipid metabolism, together mediated 80% (95% CI, 38.5 to 100%) of the
association between famine exposure and TG. Analyses restricted to those exposed to famine during early gestation
identified additional CpGs mediating the relationship with TG near PFKFB3 (glycolysis) and METTL8 (adipogenesis).
DNAm at the CpGs involved was associated with gene expression in an external data set and correlated with DNAm
levels in fat depots in additional postmortem data. Our data are consistent with the hypothesis that epigenetic me-
chanismsmediate the influence of transient adverse environmental factors in early life on long-termmetabolic health.
The specific mechanism awaits elucidation.INTRODUCTION
Since the early 1970s, epidemiological studies have reported associa-
tions between an adverse prenatal environment and an increased dis-
ease risk in later life (1). Animal studies provided potential mechanisms
for these observations (2), including environmentally induced changes
to epigenetic marks during development (3). Epigenetic marks such as
DNAmethylation (DNAm) influence the transcription potential of ge-
nomic regions and, once changed, can result in long-term effects (4).
Animal experiments show that epigenetic changes that are established
during early development contribute to phenotypes later in life (5, 6). In
parallel, human studies show changes in DNAm after exposure to a
range of adverse prenatal conditions (7–12). These DNAm differences
may mediate part of the association between adverse prenatal con-
ditions and childhood phenotypes (13–15). Systematic epigenome-wide
studies investigating the associations among these adverse condi-
tions, DNAm changes, and specific phenotypes later in life are still
largely lacking (16).To fill this gap,we examined these associations in the quasi-experimental
setting of theDutchHungerWinter of 1944–1945 (17), a 6-month fam-
ine at the end of World War II. Exposure to famine during gestation is
associated with an increased risk of obesity, dyslipidemia, type 2 diabe-
tes, and schizophrenia (18). We focus on our previous studies of the
Dutch Hunger Winter, where we documented that prenatal adversity
is associated with increases in adverse metabolic phenotypes in adult-
hood such as bodymass index (BMI) and fasting glucose, serum triglycer-
ides (TG), and low-density lipoprotein (LDL) cholesterol concentrations
(LDL-C) (19–23). Here, we adopt a genome-wide approach to systemat-
ically identify the potential of DNAm to act as a mediator of the relation
between prenatal famine exposure and adult outcomes in our study pop-
ulation of prenatally exposed individuals and time and sibling controls
(24). We use mediation analysis as a helpful statistical tool to further
explore the nature of the relationship between an independent (famine
exposure) and dependent variable (metabolic health) through a hy-
pothesized mediator (DNAm).
To formally establish mediation (25), we first re-examined the rela-
tion between famine exposure any time during gestation (“famine ex-
posure”) and adult BMI, glucose, TG, and LDL-C outcomes in
individuals with genome-wide DNAm data. Next, we examined
genome-wide whether DNAm at specific cytosine-phosphate-guanine
(CpG) dinucleotides was associated with both famine exposure and the
outcome of interest and subjected the identified candidate CpGs to a
formal mediation test (26) to determine the extent to which DNAm
mediated the association between prenatal famine and adult outcomes.
These analyses were repeated for exposure during early gestation, which
is an especially sensitive period of gestation (27, 28). To address the
potential functional impact of mediating CpGs, we tested for their1 of 10
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ation levels across postmortem studies (31, 32).
Using this approach, we show that the increase in BMI and TG
among individuals exposed in utero is mediated by DNAm, specifically
near genes involved in development and metabolic processes including
energymetabolism(PIM3),b cell function (TXNIP), glycolysis (PFKFB3),
and adipogenesis (METTL8).RESULTS
Genome-wide mediation analysis
We first confirmed the previously reported association between famine
exposure andBMI, fasted glucose, TG, andLDL-C in theDutchHunger
Winter Families Study for individuals with complete methylation data
(19–23). Individuals with prenatal famine exposure (n = 348) had a
5.6% (+0.36 SD) higher BMI (P=5.7 × 10−7), a 13.5% (+0.23 SD) higher
serumTG (P = 3.8 × 10−3), and a 3.8% (+0.22 SD) higher fasted glucose
(P = 0.023) but no difference in LDL-C (P > 0.05), as compared with
non-exposed controls (n = 463; Table 1). Therefore, LDL-C was ex-
cluded from further analyses. Next, we applied a genome-wide screen
(342,596 CpGs) to identify potentially mediating CpGs. We simulta-
neously tested the association ofDNAmwith famine exposure andwith
any of the metabolic outcomes (BMI, fasted glucose, or TG) in a single
model. For BMI and TG, this resulted in 8 and 16 associated CpG di-
nucleotides, respectively (PFDR < 0.05; Fig. 1). These were candidates for
mediation and were explored further. No mediation candidates were
identified for fasting glucose concentrations. These candidates from
the epigenome-wide association study (EWAS) can arise from a strong
association with either exposure, outcome, or both (in which case the
strength of the two associations individually may be moderate). Only
the latter constitute potentially mediating CpGs.Tobi et al., Sci. Adv. 2018;4 : eaao4364 31 January 2018Mediation: Famine exposure and BMI
Of the eight mediation candidates for the EWAS of famine exposure
and BMI, only cg09349128 was associated with both exposure and out-
come (Pexposure+bmi = 1.3 × 10
−7, Pexposure = 1.5 × 10
−3, Poutcome = 6.5 ×
10−8; Table 2). Of interest, DNAm at this CpG has been consistently
reported to be associated with BMI (33–36). A formal mediation anal-
ysis showed that DNAm at cg09349128 mediates the association be-
tween famine exposure and BMI [bmediation = 0.7%/log(BMI); 95%
confidence interval (CI), 0.3 to 1.2%; P = 0.001]. The mediation path
explained 13.4% (95% CI, 5 to 28%; P = 0.001) of the association be-
tween famine exposure and BMI (R2LMM = 0.27). This finding persisted
after statistical adjustment for smoking, socioeconomic status (SES),
and reported dietary intake at the time of examination (calories from
fat, protein, or carbohydrates or from any source).
Genomic annotation of cg09349128 revealed that it mapped to an
enhancer region in multiple cell types (37). The enhancer is linked to
PIM3 in epigenome reference data, a gene implicated in cell growth and
energy metabolism (38), stem cell renewal (39), and glucose-stimulated
insulin secretion in b cells (40). Analysis of 2044 whole blood samples
with both genome-wide DNAm (Illumina 450k) and expression [RNA
sequencing (RNA-seq)] data (29, 30) showed that methylation of
cg09349128 was associated with the expression of PIM3 and also with
two additional genes in cis, namely, ZBED4 and CRELD2 (table S1).
Mediation: Famine exposure and TG
Of the 16 mediation candidates for the association between famine ex-
posure and TG, 6 CpGs were associated with both exposure and out-
come (table S2).With the exception of cg06983052, methylation at these
CpGs was previously reported to be associated with TG or other meta-
bolic traits in EWASs (30, 41–46). All six CpGs mediated the relation
between famine exposure and TG (P < 0.007; Table 3). The mediation
path of each CpG explained between 19.6 and 28.0% of the association
between famine exposure and TG (R2LMM = 0.30). Although not map-
ping close together and often located on different chromosomes,
DNAm levels of the six CpGs were correlated (r = 0.17 to 0.73, P <
0.001). We therefore tested mediation for the mean standardized
DNAm level across all six CpGs. This aggregate measure likewise
mediated the association between famine exposure and TG [bmediation =
0.075 SD/log(TG); 95%CI, 0.047 to 0.104; P < 0.001]. Themediation path
explained 80.0% (95% CI, 38.5 to 100%; P = 0.02) of the association. The
role as mediator persisted, for both individual CpGs and their aggregate,
after additional adjustment for smoking, SES, and current diet. Adjust-
ment for BMI did somewhat attenuate this association [bmediation =
0.053 SD/log(TG); 95% CI, 0.03 to 0.08; P < 0.001], and as a result, the
proportion mediated was affected (P = 0.27). Because an additional anal-
ysis showed that the CpGs involved did not mediate the association be-
tween famine exposure andBMI (P>0.076), it is unlikely that an extended
mediation path including BMI is involved in terms of DNAm.
The six mediating CpGs mapped to (intronic) enhancers, open
chromatin regions, and exons. Analysis of blood data (29, 30) showed
that all but cg18120259 were associated with the expression of their
nearest genes (table S1). This included cg19693031 with TXNIP and
cg07397296withABCG1. DNAm at both CpGs has been previously as-
sociated with TG (30).
Mediation: Early famine exposure
Early gestation appears to be the most vulnerable period in terms of the
later-life phenotype (27) as epigenetic (28) consequences of famine ex-
posure. The association between famine exposure and BMI or TG alsoTable 1. Phenotypic differences and famine exposure.Controls Famine exposureN 463 348Age (years) [SD]+ 58.0 [5.4] 58.9 [0.5]***Male (%) 43.0 46.0BMI1 [SD] 27.0 [4.2] 28.5 [5.0]***LDL-C2 [SD] 3.42 [0.96] 3.45 [0.97]Triglycerides2 [SD] 1.48 [0.86] 1.68 [1.30]**Glucose baseline3 [SD] 5.32 [0.93] 5.52 [1.19]*Nominal P value either *P < 0.05, **P < 0.01 or ***P < 0.001 from a linear
mixed-effects model with the denoted variable as the dependent variable
and family identifier as random effect. +Model included an additional
random effect for exposure status to control for the difference in variance
in age between groups. 1Model-applied correction for age and gen-
der. 2Model-applied correction for age, gender, and statin used, and
individuals who were nonfasting at examination were excluded (excluding
two controls and five famine-exposed individuals). 3Model-applied cor-
rection for age and gender. Individuals who were nonfasting and had prediag-
nosed diabetes (thus receiving treatment) before the clinical examination were
excluded (excluding 19 controls and 32 famine-exposed individuals).2 of 10
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Fig. 1. Manhattan plots: Outcome genome-wide screens for potential mediators. The−log(P value) is shown (y axis) for eachCpG relative to its genomic locations (x axis)
on the 22 autosomal chromosomes tested for (A) an EWAS on both famine exposure and BMI and (B) an EWAS on both famine exposure and serum TG.Table 2. Genome-wide screen for potential mediators: famine exposure and BMI.TobCpG characteristicsi et al., Sci. Adv. 2018;4 : eaao4364 31 January 2018Mediation EWAS Associations with either famine exposure or BMI*CpG Location (hg19)
Nearest gene
(expression)†Methylation (SD)‡ Rank EWAS P§ EWAS PFDR bfamine Pfamine bBMI PBMI Previous EWAScg00574958 chr11:68607622 CPT1A 13.6 (2.6) 1 6.7 × 10−14 2.3 × 10−8 −0.2 0.19 −4.0 1.7 × 10−16 (33, 56, 72, 73)cg06500161 chr21:43656587 ABCG1 65.9 (3.0) 2 2.0 × 10−12 3.3 × 10−7 −0.1 0.75 4.3 2.5 × 10−13 (33, 43, 56, 73)cg26950531 chr19:38704515 DPF1 32.5 (6.1) 3 2.2 × 10−10 4.3 × 10−5 0.3 0.50 −8.9 1.3 × 10−11 (56)cg11024682 chr17:17730094 SREBF1 53.2 (3.2) 4 2.2 × 10−8 1.9 × 10−3 −0.1 0.70 3.3 1.2 × 10−9 (33, 43, 56)cg09349128 chr22:50327986 CRELD2 39.0 (3.8) 5 1.3 × 10−7 8.3 × 10−3 −0.7 1.5 × 10−3 −3.5 6.5 × 10−8 (33–36, 56)cg09737197 chr11:68607675 CPT1A 20.4 (4.6) 6 1.5 × 10−7 8.3 × 10−3 −0.4 0.093 −4.4 3.2 × 10−9 (33, 73)cg23032421 chr3:3152038 IL5RA 73.9 (4.1) 7 2.1 × 10−7 0.01 −0.3 0.18 −3.4 5.8 × 10−9 (33)cg17058475 chr11:68607737 CPT1A 16.1 (4.1) 8 7.4 × 10−7 0.032 −0.1 0.66 −4.2 2.3 × 10−8 (30, 56, 72–74)cg15659713¶ chr8:38586183 TACC1 24.6 (3.9) 9 1.7 × 10−7 0.064 1.3 1.7 × 10−7 −0.4 0.63 (28)cg26199857¶ chr12:54764265 ZNF385A 68.9 (5.7) 14 5.2 × 10−7 0.13 2.0 3.1 × 10−7 1.3 0.28 (28)*The estimate and (nominal) P value belonging to the EWAS for famine exposure (b = exposed − unexposed) or BMI (b/log(BMI)). †Nearest gene within
100 kb. ‡The Illumina 450k array b value (ranging from 0 to 1) multiplied by 100 for easy interpretation. This is done throughout the presented work. §The
P value belonging to an analysis of variance (ANOVA) test (c2, df = 2) between a generalized estimating equations (GEE) model with and without both famine
exposure and BMI. ¶The two CpGs identified in a previous EWAS on famine exposure (28).3 of 10
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exposure (table S3). Therefore, we investigated whether mediation
by DNAm is also present for the elevated BMI and TG in individ-
uals with “early” exposure. The subsequent genome-wide screens
for possible mediators of these associations did not yield candidates
for BMI that were associated with both DNAm and outcome (Fig. 2
and table S4).
Seventeen CpGs were potential mediators for the association be-
tween early exposure and TG. Two of which were associated with both
early exposure and TG (table S4). Both cg08994060 [bmediation = 4.1%
(95% CI, 0.3 to 8.3%), P = 0.033] and cg11269166 [bmediation = 3.5%
(95%CI, 0.4 to 7.2%),P= 0.027]mediated the association between early
exposure and TG (R2LMM = 0.32). The proportion mediated was 24.5%
for cg08994060 (P = 0.054), whereas cg11269166mediated 19.4% of the
association between exposure and TG (95%CI, 1.5 to 81.3%; P= 0.039).
The aggregate measure mediated the association between early expo-
sure and TG [bmediation = 0.069 SD/log(TG) (95% CI, 0.026 to 0.116),
P = 0.02], explaining 36.3% (95% CI, 15.7 to 100%; P = 0.02) of the as-
sociation. Correction for smoking, SES, and current diet had no influ-
ence on these outcomes. Additional correction for BMI attenuated the
association of cg08994060 [bmediation = 3.2% (95% CI, 0.0 to 7.0%), P =
0.052] but not of cg11269166 or their aggregate.Tobi et al., Sci. Adv. 2018;4 : eaao4364 31 January 2018CpG cg08994060 is located in a deoxyribonuclease I (DNaseI) hyper-
sensitivity cluster in an intron of PFKFB3, a rate-limiting enzyme in
glycolysis, and was associated with expression of this gene in whole
blood (table S1). Similarly, cg11269166 is located in an enhancer located
in an intron ofMETTL8, a gene involved in adipogenesis (47), and was
associated withMETTL8 expression in whole blood (table S1).
Cross-tissue comparison
Wemeasured DNAm in whole blood and do not have specimens from
other tissues available in our cohort (24). Mean differences in DNAm
levels vary between tissues (32), butDNAm level variation in bloodmay
still reflect variation in other tissues (48). We investigated DNAm data
across 12 postmortem tissue types from 16 cadavers (30, 31) and found
that the DNAm patterns in blood showed broad correspondence with
those in internal tissues [Spearman’s r = 0.42, P < 10−6; blood, liver,
kidney, skin, omentum (visceral fat), subcutaneous fat, and fat from
around the kidney], although the correlation between tissues was more
modestwhenCpGswereanalyzed individually in this small data set (fig. S3).
DNAm in blood was correlated with DNAm in omentum and sub-
cutaneous fat (both r = 0.51, P < 10−11) and fat taken from around
the kidney (r = 0.42, P = 2.7 × 10−7) but not with DNAm in the liver
(r = 0.14, P = 0.14).Table 3. Mediation analysis: DNAm and the association between famine exposure and triglycerides.CpG
Location
(hg19)Nearest
gene*Methylation
(SD)†
Rank
EWAS
PFDRPfamine PTG
Previous
studiesbmediation
‡ P
mediation
m
Proportion
ediated (%)
[95% CI]§
Pproportioncg19693031 chr1:145441552 TXNIP 77.5 (4.3) 6 2.6 × 10−5 4.8 × 10−3 2.3 × 10−11 (41–45) 2.6 [0.7–4.8] 0.005 28.0 [5.7–100] 0.026cg18120259 chr6:43894639 LOC100132354 60.4 (4.7) 10 1.8 × 10−3 6.6 × 10−4 6.4 × 10−8 (44) 2.3 [0.8–4.1] 0.001 24.9 [7.5–100] 0.021cg15020801 chr17:46022809 PNPO 36.1 (3.4) 12 3.5 × 10−3 7.1 × 10−4 6.0 × 10−8 (30) 2.3 [0.9–4.2] 0.001 25 [7.0–100] 0.022cg06983052 chr1:90288099 LRRC8D 64.8 (3.8) 13 4.2 × 10−3 1.0 × 10−5 5.3 × 10−6 2.6 [1.1–4.5] <0.001 28.0 [8.8–100] 0.024cg07397296 chr21:43655316 ABCG1 26.9 (3.8) 14 0.021 5.1 × 10−3 1.9 × 10−7 (49) 1.9 [0.6–3.6] 0.005 20.5 [4.6–97.4] 0.027cg20496314 chr22:39759864 SYNGR1 40.2 (4.3) 15 0.032 3.9 × 10−3 1.5 × 10−7 (45, 46) 1.8 [0.5–3.5] 0.007 19.6 [3.6–88.3] 0.026*Nearest gene within 100 kb. †The Illumina 450k array b value (ranging from 0 to 1) multiplied by 100 for easy interpretation. ‡This is the estimate and
CI based on 10K Monte Carlo simulations of the indirect effect or mediation effect, which is often referred to as the “a × b” effect. §The percentage of the
total exposure-phenotype relationship explained by the indirect (mediated) effect as based on 10K Monte Carlo simulations.Early exposure and TG
cg17901584
cg19693031
cg11269166
cg06649410
cg00574958cg17058475
cg26262157
cg08994060
cg05014727
cg09737197
cg11496778
cg10354880
cg11024682
cg27370573
cg06500161
cg22307029
cg24324837
Fig. 2. Manhattan plot: Outcome genome-wide screen for potential mediators. The −log(P value) (y axis) for each CpG relative to its genomic locations (x axis) on the 22
autosomal chromosomes for the EWAS for both early famine exposure and serum TG.4 of 10
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A stepwise genome-wide mediation analysis is consistent with the hy-
pothesis that epigenetic mechanisms play a role in mediating the asso-
ciation between prenatal famine exposure and later-life metabolic
health. Specifically, our results suggest that DNAm at an enhancer
linked to PIM3 expressionmediated the association between famine ex-
posure and BMI. PIM3 influences cell growth and energy metabolism,
includingmitochondrial function (38). DNAmat six CpGs, including at
previously TG-associated CpGs at TXNIP and ABCG1 (41–45, 49),
mediated the association between famine exposure and TG. DNAm
at these CpGs was likewise associated with the expression of genes im-
plicated in cell growth and energy metabolism. Two different CpGs, at
PFKFB3 (which plays a key role in glycolysis) andMETTL8 (linked to
adipogenesis), mediated the association between early exposure and TG.
DNAmat thenine identifiedCpGscorrelatedwithDNAminvariousother
tissues, includingmultiple fat deposits. DNAmat the nineCpGs associated
with the expression of genes with general roles in growth andmetabolism,
and althoughmediators, they are not known to play direct roles in fat and
TG metabolism. Therefore, the nine CpGs are unlikely to be directly
involved in amechanistic sense in BMI or TGbut may have contributed
to adverse morphological or cellular metabolic profiles with an ad-
verse effect on metabolic health in prenatally exposed individuals.
We used a novel approach to identify possible mediators by per-
forming a series of genome-wide analyses that tested for an association
with DNAm of both the exposure and a metabolic outcome simulta-
neously. This resulted in a set of CpGs associated with either famine
exposure or a later-life metabolic outcome, or both. The latter were for-
mally tested for mediation. CpGs that associated with (early) famine
exposure in our previous EWAS of famine exposure only in the same
data set (28) were not identified as potential mediators (that is, were
associated with exposure but not with outcome). In concordance with
this (28) and earlier work (50–52), all the mediating CpGs overlapped
regulatory elements; were linked to the expression of genes involved in
growth, differentiation, and metabolism; and were associated with ei-
ther famine exposure or early famine exposure. It should be noted that
the latter analysis was based on a small sample size and had limited
power, but the results may point to additional processes unique for
those exposed during early gestation.
Several strengths and limitations of this study and mediation analy-
ses in general are important to discuss.We observed that the association
between prenatal famine and BMI or TG was mediated by single CpGs
(instead of regions). This observation may be related to technical (that
is, the sparsity of the Illumina 450k array) and biological factors [differ-
entialmethylationmay be related to very local differences in transcription
factor binding, not extending across regions (29)]. We recognize that
statistical evidence for mediation does not clarify the nature of the
mechanism. However, it does point toward possible pathways that war-
rant further exploration. It is also relevant to note that DNAm was
measured in whole blood, which may not be the most relevant tissue
to study for BMI or TG. However, DNAm data from multiple tissues
from the same donor (31, 32) show a broad agreement in DNAm
patterns of the CpGs in whole blood and various fat deposits. Moreover,
two previous studies showed that the associations between DNAm at
PIM3 (cg09349128) and BMI (33) and DNAm at ABCG1 (cg07397296)
and TG (49), on which we likewise report here, were not only found in
blood but could also be validated inDNAmdata fromadipose tissue.Our
findings may therefore point toward more general processes in other
tissues, including adipose tissue, andmay reflect other epigenetic marks
correlated to DNAm.Tobi et al., Sci. Adv. 2018;4 : eaao4364 31 January 2018Mediation analysis is sensitive to unmeasured confounding (53).We
address this concern, within the limits of an observational study six dec-
ades after the exposure, on several levelswith our study design and study
execution. First, we analyzed the impact of prenatal famine exposure among
same-sex sibling pairs concordant and discordant on famine exposure,
thereby mitigating confounding by familial factors. Next, we selected indi-
viduals born before and after the famine in the same institutions as controls
for those with prenatal famine exposure and rely on the quasi-experimental
circumstances of theDutchFamine, precluding confoundingby social char-
acteristics related to wealth and nutrition in pregnancy. The inclusion of
individuals either conceived and born before the famine or conceived and
bornafter the faminealsoallowsus to investigate andadjust for the influence
of age, which is crucial (54). Last, we could effectively exclude confounding
effects of several measured lifestyle factors including diet and smoking.
We recognize that the interpretation ofmediation analyses requires pru-
dence (53) becausemediation analysis is sensitive to differences inmeasure-
ment accuracy between observed exposure and an empirically measured
mediator. However, this risk is reduced by the quasi-experimental
setting of our study. Also,mediation analysis is equally sensitive for spu-
rious associations as regular association analysis (53). Of the nine
mediating CpGs identified here, all but cg06983052 (LRRC8D) have been
related to obesity, TG, or other metabolic phenotypes in previous studies
(Tables 2 and 3). In addition, mediation can also be affected by reverse
causation (53). Prenatal famine exposure may be considered a causal
anchor that, while not as strong as genetic variants inMendelian random-
ization (53), reduces the risk of reverse causation for several of the tests
performed within themediation framework with the exception of the as-
sociation between mediator and outcome (55). Longitudinal data could
be used to refute reverse causation (preferably from conception onward),
but by design, we did not sample at birth or any other time at a younger
age before the potential onset of the metabolic complications.
The nine CpGs onwhich we report include the well-described CpGs
mapping to PIM3 (cg09349128) (33–36, 56) and TXNIP (cg19693031)
(30, 41–44) that were also reported in largeMendelian randomization
studies (30, 33, 56).No evidencewas found for an effect of BMIonDNAm
at cg09349128 (33, 56), whereas weak evidence was found for an effect of
TG onDNAm at cg19693031 (30). However, DNAm at this latter CpG is
also associated with prenatal smoke exposure (45) [and not adult smoke
exposure (11)], an exposure likewise linked with elevated serum TG (57).
DNAmat thisCpG is also associatedwith future type 2diabetes risk that is
independent of the traditional risk factors, which included dyslipidemia
(43), analogs to the association between prenatal famine exposure, and
type 2 diabetes (20). The overlap with previous EWAS findings highlights
not only the fact that we are looking at epigenetic variation with amodest
individual impact on variation in metabolic health but also the idea that
the relevance of our results may extend beyond prenatal famine exposure.
In summary, using a systematic genome-wide approach,we show that
DNAm at specific CpGs mediates a considerable proportion of the asso-
ciations between prenatal famine exposure and later-life adiposity and
serum TG levels. Our data are consistent with the hypothesis that the
associations between exposure to an adverse environment during early
development and health outcomes in adulthood are mediated by epige-
netic factors. The specific causal mechanism awaits elucidation.MATERIALS AND METHODS
Study setting
The Dutch Hunger Winter was a 6-month famine at the end of World
War II that resulted from a combination of punitive measures imposed5 of 10
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conditions, and fuel shortages related to war operations. Food rations
were distributed centrally and rapidly dropped to below 900 kcal/day
between 26 November 1944 and 15 May 1945. After 15 May, rations
rapidly returned to pre-famine levels. The percentage of calories from
proteins, fat, and carbohydrates in the diet was relatively constant as the
food rations diminished (17, 58).
Study subjects
The Dutch Hunger Winter Families study is described in detail else-
where (24). We identified 2417 singleton births between 1 February
1945 and 31 March 1946 at three institutions in famine-exposed cities
in the western Netherlands whose mothers were exposed to the famine
during or immediately preceding that pregnancy. We selected time
controls born in 1943 or in 1947 from the same clinics. We also asked
whether a same-sex sibling not exposed to the famine would be willing
to participate as a sibling control. Both the famine-exposed and the time
controls can therefore have a same-sex sibling as family control. Overall,
1075 interviews and 971 clinical examinationswere performed six decades
after the exposure. Following the Helsinki guidelines, we obtained
ethical approval, both from the Institutional Review Board of Columbia
University Medical Center and from the Medical Ethical Committee of
the Leiden University Medical Center. The study participants provided
verbal consent in a telephone interview, and in case of clinical examina-
tions, a written informed consent was obtained.
Famine exposure definitions
We defined famine exposure by the number of weeks during which the
mother was exposed to <900 kcal/day after the last menstrual period
(LMP) recorded on the birth record. Missing or implausible LMP re-
cords (12%) were (re-)estimated from the birth weights and the date of
birth (24). We considered somebody exposed to famine in gestational
weeks 1 to 10, 11 to 20, 21 to 30, or 31 to delivery if such a gestational
time window was entirely contained within this period and had an av-
erage exposure of <900 kcal/day during this 10-week period. As a result
of the 6-month duration, some individuals were exposed to two adja-
cent 10-week periods. In short, pregnancies with an LMP between 26
November 1944 and 4 March 1945 were exposed in weeks 1 to 10,
those with an LMP between 18 September 1944 and 24 December
1944 were exposed in weeks 11 to 20, those with an LMP between 10 July
1944 and 15October 1944were exposed in weeks 21 to 30, and those with
an LMP between 2May 1944 and 24 August 1944 were exposed in weeks
31 to delivery. We defined individuals exposed in any of these periods as
“famine-exposed,” and those exposed in gestational weeks 1 to 10 were
defined as early exposed. In addition, individuals with an LMP between
1February and 12May 1945were exposed to an average of <900 kcal/day
for 10 weeks before conception and were defined as the preconception
exposure group.
Characteristics
Medical examinations were scheduled early in the morning under
fasting conditions.Measurement of heightwas carried out to the nearest
millimeter using a portable stadiometer (Seca), and body weight was
measured to the nearest 100 g by a portable scale (Seca). BMI was
calculated from these measures. A blood draw was performed at the
start of a 75-g oral glucose test, and glucose was quickly assessed in serum
by hexokinase reaction on a Modular P800 (Roche). Cholesterol mea-
sures were reported earlier (19) and were assessed using standard
enzymatic assays. LDL-C was calculated for individuals with a TG con-Tobi et al., Sci. Adv. 2018;4 : eaao4364 31 January 2018centration lower than 400 mg/dl using the Friedewald formula. Dietary
intake in the last 12 months was ascertained from a 140-item food fre-
quency questionnaire developed to assess dietary habits in an elderly
Dutch population (59). This questionnaire provided estimates of mac-
ronutrient intake (total energy and the percentage of fat, protein, and
carbohydrate thereof ). As a measure of SES, we classified study partic-
ipants on a five-level education scale, identifying individuals with
primary, lower- ormiddle-level vocational, secondary, higher vocational,
and university education.
DNAm data
DNAm was measured using the Illumina Infinium Human Methyla-
tion 450k BeadChip, and preprocessing was previously described by
us in detail (28). Briefly, samples were randomly distributed, ensuring
similar distributions of exposure periods, sex ratios, and mean ages per
96-well plate and 450k array, keeping sibling pairs together, but were
randomly assigned to either the left or right column of the 450k array.
We assessed data quality using both sample-dependent and sample-
independent quality metrics using the R package MethylAid (60). Bi-
sulfite conversion efficiencywas assessed using the dedicated 450k probes
and sequencing the IGF2 DMR0 of a random set of samples. We re-
measured a subset of the genotypes measured on the 450k array with
MassARRAYand checked the gender of samples using all X-chromosomal
CpGs to exclude sample swaps.We used noob and Functional Normal-
ization as implemented in the minfi package (61) using six principal
components to normalize for batch effects, dye color intensity differ-
ences, and background signal. Individual measurements with a detec-
tion P value of >0.01 or zero-intensity value in one of the used color
channels were set as missing. The measurement success rate per sample
was>99%.Next,we removeda-specific/polymorphic andnon-autosomal
probes, probes with <95% success rate, and those probes that were com-
pletelymethylated or unmethylated in allmajor cell types inwhole blood.
Methylation percentages in text, figures, and tables reflect microarray
b-value estimates (which range from close to zero to close to one or
0 to 100%, as denoted throughout). For the individuals for whomwe have
genome-wideDNAmdata (Illumina 450k array), 348 individualsmet our
definition of famine exposure, of whom 73 also meet the definition of ex-
posure during weeks 1 through 10 of gestation (early exposure). In total,
94 individualsmet our preconception exposure definition. In addition,
we have 463 individuals with no famine exposure directly before con-
ception and during gestation. DNAm data are available upon request.
In addition, we used DNAm data from 16 obductions (31, 32) from
which samples were collected within 12 hours of death (mean age,
62.8 years). Inconcordancewith theethical guidelines in theCode forProper
SecondaryUseofHumanTissue in theNetherlands (DutchFederationof
Medical Scientific Societies), these samples were anonymized, and raw
data have been deposited in theNational Center for Biotechnology Infor-
mation’s Gene ExpressionOmnibus (GSE78743). To explore the relation
with gene expression and validate associations with BMI or TG, we
referred to the DNAm data of 3296 individuals (30) measured within
the Genome of the Netherlands reference project [GoNL; deposited at
the EuropeanGenome-phenomeArchive (EGA) under accession num-
ber EGAC00001000277]. Preprocessing and normalization were done
as described above for both data sets. R Code for the quality control and
normalization is provided at https://git.lumc.nl/molepi/DNAmArray.
Gene expression data
WeusedRNA-seqdata created fromtotalRNAextracted fromwholeblood
using the TruSeq v2 library protocol and 2 × 50–base pair paired-end6 of 10
SC I ENCE ADVANCES | R E S EARCH ART I C L Esequencing on an Illumina HiSeq2000 for 2044 of the 3296 individ-
uals for which we have DNAmdata from the GoNL reference project
(likewise under EGA accession number EGAC00001000277). Data
processing is detailed elsewhere (29) and consisted in removal of bar-
coded adapters, low-quality reads, alignment against genome build
NCBI37, and gene-annotation Ensembl v.71, normalization, and
GC-bias correction.
Statistics
All analyses were performed in the R programming environment
(R.3.2.2). Reanalysis of the associations between phenotypes and famine
exposurewas performedwith linearmixed-effectsmodels (LMMs)with
one of the phenotypes (BMI, TG, glucose, and LDL-C) as the dependent
variable using the R lme4 package (62). The sibling-pair identifier was
included as a random effect, and where appropriate, we corrected for
gender and age at examination. We used the restricted maximum like-
lihoodmethod and variance components for the covariancematrix struc-
ture. The degree of freedom (df) for a variable of interest was calculated
with Satterthwaite’s approximation, as implemented in the R package
lmerTest (63). The R2 for the LMMswas assessed using the RMuMIn
package (64). In line with previous reports (19, 20, 23, 65, 66), we
included statin usage when assessing cholesterol variables, excluded
nonfasting individuals for the cholesterol analyses, and excluded in-
dividuals with diagnosed diabetes (and therefore on medication)
before the clinical examinations for the analyses of fasting serum glucose
levels.
For their robustness, we used generalized estimating equations as
implemented in the R geepack package (67) for the series of EWAS
for potential mediators. We used a Gaussian link function to model
DNAm (reflected by the 450k array b value). In each EWAS, we added
the following as covariates: gender, age at examination (scaled and
centered), row on the 450k array, one variable denoting the batch
(unique combination of bisulfite conversion plate and scan batch),
the first three principal variance components as a proxymeasure for cell
heterogeneity, and, where appropriate, additional corrections specific
for the phenotype of interest (BMI, TG, and glucose). We controlled
for correlation within sibships in the GEE, thereby addressing (un-
measured) confounding on the familial level. We compared this model
with an extension additionally containing both the phenotype of inter-
est and a zero-one variable denoting the famine exposure status. Model
fits were compared using analysis of variance (ANOVA), yielding a
c2 statistic for evaluation (df = 2). Each EWAS was corrected for
genome-wide inflation by dividing the c2 statistic by the inflation
factor (l) (68), and results were adjusted for multiple testing using
false discovery rate (FDR) correction (69) where appropriate. The l
ranged between 1.12 and 1.19. Inflation was caused by the fact that
sibling pairs were measured on the same microarrays (28). When
sibling pairs and unrelated individuals are analyzed separately, the l
is close to one.
To quantify the mediation effect of DNAm, we performed model-
based mediation analysis using the method originally developed by
Imai et al. (25) in the R mediation package (26), which implements
LMM and other advanced statistical models in a causal mediation
testing framework. Mediation analysis on multiple CpGs was simul-
taneously performed on themean of the standardized b values that were
multiplied by the directionality of the association for each CpG (times
−1 for negative relationships between DNAm and famine exposure and
the later-life phenotype).We report on the bmediation, more often referred
to as the estimate of the indirect/mediation path or “a × b” effect, and theTobi et al., Sci. Adv. 2018;4 : eaao4364 31 January 2018proportion mediated, the percentage of the total effect on the outcome
explained by the indirect/mediation path. CIs and test statistics for these
measures were estimated by 10,000 Monte Carlo simulations.
DNAm was linked to gene expression in cis (<100 kb) by first
performing an EWAS using the R package CATE (70) with DNAm
of one mediating CpG as the dependent variable and correcting for
age and gender and five latent variables (using the “ed” eigenvalue
difference method). Possible inflation and bias inherent to the correla-
tion structure of both DNAm and gene expression data were corrected
using the R package bacon (71). Corrected estimates, standard errors,
and test statistics for only those genes within 100 kb were then assessed
and corrected by FDR for multiple testing. All P values reported were
two-sided.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
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